English
简体中文
Total: £ 56.28
Published Date: 2024-04-08 | Pages: 106 | Tables: 230 | Pharma & Healthcare
Paclitaxel Injection is a kind of anti-cancer injection taking paclitaxel API as raw material. It is mainly used in breast cancer, ovarian cancer and other cancers.
Paclitaxel injection comes as a liquid to be given intravenously (into a vein) by a doctor or nurse in a hospital or clinic. It is usually given once every 3 weeks. When paclitaxel injection manufactured with polyoxyethylated castor oil is used to treat Kaposi's sarcoma, it may be given once every 2 or 3 weeks.
The global Paclitaxel for Injection market was valued at US$ 3384 million in 2023 and is anticipated to reach US$ 7025.7 million by 2030, witnessing a CAGR of 11.0% during the forecast period 2024-2030.
Paclitaxel injection is a chemotherapy drug used to treat many types of cancer. It is mainly used as an anti-tumor drug, and has a wide range of applications in the treatment of ovarian cancer, breast cancer, non-small cell lung cancer and gastrointestinal tumors. Its market overview is as follows:
a. Market demand: With the increase in the number of cancer patients, the demand for anti-tumor drugs is also increasing. Paclitaxel injection, as a commonly used antitumor drug, has been widely recognized and used by clinicians and patients.
b. Market competition: There are other similar anti-tumor drugs on the market, such as paclitaxel injection. Although these drugs have some overlap in the treatment of cancer, there may be differences in specific applications and effects. Therefore, paclitaxel injection also needs to face market competition pressure from competitors.
c. Market size: The market size of Paclitaxel injection is relatively large. With the continuous progress of clinical research and the emergence of new treatment options, the market size is expected to continue to grow.
This report aims to provide a comprehensive presentation of the global market for Paclitaxel for Injection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Paclitaxel for Injection.
Report Scope
The Paclitaxel for Injection market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Paclitaxel for Injection market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Paclitaxel for Injection manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Getwell Pharmaceuticals
CSPC Pharmaceutical Group Limited
AdvaCare Pharma
Pfizer
Bristol-Myers Squibb
Celgene Corporation
Hospira
Biological E.
Taj Accura
Luye Pharma
Youcare Pharmaceutical
Hainan Chuntch Pharmaceutical Co Ltd
Healthiza Lifescience Private Limited
Beijing Union Pharmaceutical Factory
Hengrui Pharmaceuticals
Qilu Pharmaceutical Co., Ltd.
Hainan Haiyao
Segment by Type
5ml,30mg
10ml,60mg
16.7ml,100mg
25ml,150mg
50ml,300mg
Segment by Application
Ovarian Cancer
Breast Cancer
Cervical Cancer
Pancreatic Cancer
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Paclitaxel for Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Paclitaxel for Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Paclitaxel for Injection Market Overview
1.1 Product Overview and Scope of Paclitaxel for Injection
1.2 Paclitaxel for Injection Segment by Type
1.2.1 Global Paclitaxel for Injection Market Value Comparison by Type (2024-2030)
1.2.2 5ml,30mg
1.2.3 10ml,60mg
1.2.4 16.7ml,100mg
1.2.5 25ml,150mg
1.2.6 50ml,300mg
1.3 Paclitaxel for Injection Segment by Application
1.3.1 Global Paclitaxel for Injection Market Value by Application: (2024-2030)
1.3.2 Ovarian Cancer
1.3.3 Breast Cancer
1.3.4 Cervical Cancer
1.3.5 Pancreatic Cancer
1.3.6 Others
1.4 Global Paclitaxel for Injection Market Size Estimates and Forecasts
1.4.1 Global Paclitaxel for Injection Revenue 2019-2030
1.4.2 Global Paclitaxel for Injection Sales 2019-2030
1.4.3 Global Paclitaxel for Injection Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Paclitaxel for Injection Market Competition by Manufacturers
2.1 Global Paclitaxel for Injection Sales Market Share by Manufacturers (2019-2024)
2.2 Global Paclitaxel for Injection Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Paclitaxel for Injection Average Price by Manufacturers (2019-2024)
2.4 Global Paclitaxel for Injection Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Paclitaxel for Injection, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Paclitaxel for Injection, Product Type & Application
2.7 Paclitaxel for Injection Market Competitive Situation and Trends
2.7.1 Paclitaxel for Injection Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Paclitaxel for Injection Players Market Share by Revenue
2.7.3 Global Paclitaxel for Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Paclitaxel for Injection Retrospective Market Scenario by Region
3.1 Global Paclitaxel for Injection Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Paclitaxel for Injection Global Paclitaxel for Injection Sales by Region: 2019-2030
3.2.1 Global Paclitaxel for Injection Sales by Region: 2019-2024
3.2.2 Global Paclitaxel for Injection Sales by Region: 2025-2030
3.3 Global Paclitaxel for Injection Global Paclitaxel for Injection Revenue by Region: 2019-2030
3.3.1 Global Paclitaxel for Injection Revenue by Region: 2019-2024
3.3.2 Global Paclitaxel for Injection Revenue by Region: 2025-2030
3.4 North America Paclitaxel for Injection Market Facts & Figures by Country
3.4.1 North America Paclitaxel for Injection Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Paclitaxel for Injection Sales by Country (2019-2030)
3.4.3 North America Paclitaxel for Injection Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Paclitaxel for Injection Market Facts & Figures by Country
3.5.1 Europe Paclitaxel for Injection Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Paclitaxel for Injection Sales by Country (2019-2030)
3.5.3 Europe Paclitaxel for Injection Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Paclitaxel for Injection Market Facts & Figures by Country
3.6.1 Asia Pacific Paclitaxel for Injection Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Paclitaxel for Injection Sales by Country (2019-2030)
3.6.3 Asia Pacific Paclitaxel for Injection Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Paclitaxel for Injection Market Facts & Figures by Country
3.7.1 Latin America Paclitaxel for Injection Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Paclitaxel for Injection Sales by Country (2019-2030)
3.7.3 Latin America Paclitaxel for Injection Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Paclitaxel for Injection Market Facts & Figures by Country
3.8.1 Middle East and Africa Paclitaxel for Injection Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Paclitaxel for Injection Sales by Country (2019-2030)
3.8.3 Middle East and Africa Paclitaxel for Injection Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Paclitaxel for Injection Sales by Type (2019-2030)
4.1.1 Global Paclitaxel for Injection Sales by Type (2019-2024)
4.1.2 Global Paclitaxel for Injection Sales by Type (2025-2030)
4.1.3 Global Paclitaxel for Injection Sales Market Share by Type (2019-2030)
4.2 Global Paclitaxel for Injection Revenue by Type (2019-2030)
4.2.1 Global Paclitaxel for Injection Revenue by Type (2019-2024)
4.2.2 Global Paclitaxel for Injection Revenue by Type (2025-2030)
4.2.3 Global Paclitaxel for Injection Revenue Market Share by Type (2019-2030)
4.3 Global Paclitaxel for Injection Price by Type (2019-2030)
5 Segment by Application
5.1 Global Paclitaxel for Injection Sales by Application (2019-2030)
5.1.1 Global Paclitaxel for Injection Sales by Application (2019-2024)
5.1.2 Global Paclitaxel for Injection Sales by Application (2025-2030)
5.1.3 Global Paclitaxel for Injection Sales Market Share by Application (2019-2030)
5.2 Global Paclitaxel for Injection Revenue by Application (2019-2030)
5.2.1 Global Paclitaxel for Injection Revenue by Application (2019-2024)
5.2.2 Global Paclitaxel for Injection Revenue by Application (2025-2030)
5.2.3 Global Paclitaxel for Injection Revenue Market Share by Application (2019-2030)
5.3 Global Paclitaxel for Injection Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Getwell Pharmaceuticals
6.1.1 Getwell Pharmaceuticals Corporation Information
6.1.2 Getwell Pharmaceuticals Description and Business Overview
6.1.3 Getwell Pharmaceuticals Paclitaxel for Injection Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Getwell Pharmaceuticals Paclitaxel for Injection Product Portfolio
6.1.5 Getwell Pharmaceuticals Recent Developments/Updates
6.2 CSPC Pharmaceutical Group Limited
6.2.1 CSPC Pharmaceutical Group Limited Corporation Information
6.2.2 CSPC Pharmaceutical Group Limited Description and Business Overview
6.2.3 CSPC Pharmaceutical Group Limited Paclitaxel for Injection Sales, Revenue and Gross Margin (2019-2024)
6.2.4 CSPC Pharmaceutical Group Limited Paclitaxel for Injection Product Portfolio
6.2.5 CSPC Pharmaceutical Group Limited Recent Developments/Updates
6.3 AdvaCare Pharma
6.3.1 AdvaCare Pharma Corporation Information
6.3.2 AdvaCare Pharma Description and Business Overview
6.3.3 AdvaCare Pharma Paclitaxel for Injection Sales, Revenue and Gross Margin (2019-2024)
6.3.4 AdvaCare Pharma Paclitaxel for Injection Product Portfolio
6.3.5 AdvaCare Pharma Recent Developments/Updates
6.4 Pfizer
6.4.1 Pfizer Corporation Information
6.4.2 Pfizer Description and Business Overview
6.4.3 Pfizer Paclitaxel for Injection Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Pfizer Paclitaxel for Injection Product Portfolio
6.4.5 Pfizer Recent Developments/Updates
6.5 Bristol-Myers Squibb
6.5.1 Bristol-Myers Squibb Corporation Information
6.5.2 Bristol-Myers Squibb Description and Business Overview
6.5.3 Bristol-Myers Squibb Paclitaxel for Injection Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Bristol-Myers Squibb Paclitaxel for Injection Product Portfolio
6.5.5 Bristol-Myers Squibb Recent Developments/Updates
6.6 Celgene Corporation
6.6.1 Celgene Corporation Corporation Information
6.6.2 Celgene Corporation Description and Business Overview
6.6.3 Celgene Corporation Paclitaxel for Injection Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Celgene Corporation Paclitaxel for Injection Product Portfolio
6.6.5 Celgene Corporation Recent Developments/Updates
6.7 Hospira
6.6.1 Hospira Corporation Information
6.6.2 Hospira Description and Business Overview
6.6.3 Hospira Paclitaxel for Injection Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Hospira Paclitaxel for Injection Product Portfolio
6.7.5 Hospira Recent Developments/Updates
6.8 Biological E.
6.8.1 Biological E. Corporation Information
6.8.2 Biological E. Description and Business Overview
6.8.3 Biological E. Paclitaxel for Injection Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Biological E. Paclitaxel for Injection Product Portfolio
6.8.5 Biological E. Recent Developments/Updates
6.9 Taj Accura
6.9.1 Taj Accura Corporation Information
6.9.2 Taj Accura Description and Business Overview
6.9.3 Taj Accura Paclitaxel for Injection Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Taj Accura Paclitaxel for Injection Product Portfolio
6.9.5 Taj Accura Recent Developments/Updates
6.10 Luye Pharma
6.10.1 Luye Pharma Corporation Information
6.10.2 Luye Pharma Description and Business Overview
6.10.3 Luye Pharma Paclitaxel for Injection Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Luye Pharma Paclitaxel for Injection Product Portfolio
6.10.5 Luye Pharma Recent Developments/Updates
6.11 Youcare Pharmaceutical
6.11.1 Youcare Pharmaceutical Corporation Information
6.11.2 Youcare Pharmaceutical Paclitaxel for Injection Description and Business Overview
6.11.3 Youcare Pharmaceutical Paclitaxel for Injection Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Youcare Pharmaceutical Paclitaxel for Injection Product Portfolio
6.11.5 Youcare Pharmaceutical Recent Developments/Updates
6.12 Hainan Chuntch Pharmaceutical Co Ltd
6.12.1 Hainan Chuntch Pharmaceutical Co Ltd Corporation Information
6.12.2 Hainan Chuntch Pharmaceutical Co Ltd Paclitaxel for Injection Description and Business Overview
6.12.3 Hainan Chuntch Pharmaceutical Co Ltd Paclitaxel for Injection Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Hainan Chuntch Pharmaceutical Co Ltd Paclitaxel for Injection Product Portfolio
6.12.5 Hainan Chuntch Pharmaceutical Co Ltd Recent Developments/Updates
6.13 Healthiza Lifescience Private Limited
6.13.1 Healthiza Lifescience Private Limited Corporation Information
6.13.2 Healthiza Lifescience Private Limited Paclitaxel for Injection Description and Business Overview
6.13.3 Healthiza Lifescience Private Limited Paclitaxel for Injection Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Healthiza Lifescience Private Limited Paclitaxel for Injection Product Portfolio
6.13.5 Healthiza Lifescience Private Limited Recent Developments/Updates
6.14 Beijing Union Pharmaceutical Factory
6.14.1 Beijing Union Pharmaceutical Factory Corporation Information
6.14.2 Beijing Union Pharmaceutical Factory Paclitaxel for Injection Description and Business Overview
6.14.3 Beijing Union Pharmaceutical Factory Paclitaxel for Injection Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Beijing Union Pharmaceutical Factory Paclitaxel for Injection Product Portfolio
6.14.5 Beijing Union Pharmaceutical Factory Recent Developments/Updates
6.15 Hengrui Pharmaceuticals
6.15.1 Hengrui Pharmaceuticals Corporation Information
6.15.2 Hengrui Pharmaceuticals Paclitaxel for Injection Description and Business Overview
6.15.3 Hengrui Pharmaceuticals Paclitaxel for Injection Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Hengrui Pharmaceuticals Paclitaxel for Injection Product Portfolio
6.15.5 Hengrui Pharmaceuticals Recent Developments/Updates
6.16 Qilu Pharmaceutical Co., Ltd.
6.16.1 Qilu Pharmaceutical Co., Ltd. Corporation Information
6.16.2 Qilu Pharmaceutical Co., Ltd. Paclitaxel for Injection Description and Business Overview
6.16.3 Qilu Pharmaceutical Co., Ltd. Paclitaxel for Injection Sales, Revenue and Gross Margin (2019-2024)
6.16.4 Qilu Pharmaceutical Co., Ltd. Paclitaxel for Injection Product Portfolio
6.16.5 Qilu Pharmaceutical Co., Ltd. Recent Developments/Updates
6.17 Hainan Haiyao
6.17.1 Hainan Haiyao Corporation Information
6.17.2 Hainan Haiyao Paclitaxel for Injection Description and Business Overview
6.17.3 Hainan Haiyao Paclitaxel for Injection Sales, Revenue and Gross Margin (2019-2024)
6.17.4 Hainan Haiyao Paclitaxel for Injection Product Portfolio
6.17.5 Hainan Haiyao Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Paclitaxel for Injection Industry Chain Analysis
7.2 Paclitaxel for Injection Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Paclitaxel for Injection Production Mode & Process
7.4 Paclitaxel for Injection Sales and Marketing
7.4.1 Paclitaxel for Injection Sales Channels
7.4.2 Paclitaxel for Injection Distributors
7.5 Paclitaxel for Injection Customers
8 Paclitaxel for Injection Market Dynamics
8.1 Paclitaxel for Injection Industry Trends
8.2 Paclitaxel for Injection Market Drivers
8.3 Paclitaxel for Injection Market Challenges
8.4 Paclitaxel for Injection Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Paclitaxel for Injection Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Paclitaxel for Injection Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Paclitaxel for Injection Market Competitive Situation by Manufacturers in 2023
Table 4. Global Paclitaxel for Injection Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Paclitaxel for Injection Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Paclitaxel for Injection Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Paclitaxel for Injection Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Paclitaxel for Injection Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Paclitaxel for Injection, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Paclitaxel for Injection, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Paclitaxel for Injection, Product Type & Application
Table 12. Global Key Manufacturers of Paclitaxel for Injection, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Paclitaxel for Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Paclitaxel for Injection as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Paclitaxel for Injection Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Paclitaxel for Injection Sales by Region (2019-2024) & (K Units)
Table 18. Global Paclitaxel for Injection Sales Market Share by Region (2019-2024)
Table 19. Global Paclitaxel for Injection Sales by Region (2025-2030) & (K Units)
Table 20. Global Paclitaxel for Injection Sales Market Share by Region (2025-2030)
Table 21. Global Paclitaxel for Injection Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Paclitaxel for Injection Revenue Market Share by Region (2019-2024)
Table 23. Global Paclitaxel for Injection Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Paclitaxel for Injection Revenue Market Share by Region (2025-2030)
Table 25. North America Paclitaxel for Injection Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Paclitaxel for Injection Sales by Country (2019-2024) & (K Units)
Table 27. North America Paclitaxel for Injection Sales by Country (2025-2030) & (K Units)
Table 28. North America Paclitaxel for Injection Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Paclitaxel for Injection Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Paclitaxel for Injection Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Paclitaxel for Injection Sales by Country (2019-2024) & (K Units)
Table 32. Europe Paclitaxel for Injection Sales by Country (2025-2030) & (K Units)
Table 33. Europe Paclitaxel for Injection Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Paclitaxel for Injection Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Paclitaxel for Injection Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Paclitaxel for Injection Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Paclitaxel for Injection Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Paclitaxel for Injection Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Paclitaxel for Injection Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Paclitaxel for Injection Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Paclitaxel for Injection Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Paclitaxel for Injection Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Paclitaxel for Injection Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Paclitaxel for Injection Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Paclitaxel for Injection Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Paclitaxel for Injection Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Paclitaxel for Injection Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Paclitaxel for Injection Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Paclitaxel for Injection Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Paclitaxel for Injection Sales (K Units) by Type (2019-2024)
Table 51. Global Paclitaxel for Injection Sales (K Units) by Type (2025-2030)
Table 52. Global Paclitaxel for Injection Sales Market Share by Type (2019-2024)
Table 53. Global Paclitaxel for Injection Sales Market Share by Type (2025-2030)
Table 54. Global Paclitaxel for Injection Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Paclitaxel for Injection Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Paclitaxel for Injection Revenue Market Share by Type (2019-2024)
Table 57. Global Paclitaxel for Injection Revenue Market Share by Type (2025-2030)
Table 58. Global Paclitaxel for Injection Price (US$/Unit) by Type (2019-2024)
Table 59. Global Paclitaxel for Injection Price (US$/Unit) by Type (2025-2030)
Table 60. Global Paclitaxel for Injection Sales (K Units) by Application (2019-2024)
Table 61. Global Paclitaxel for Injection Sales (K Units) by Application (2025-2030)
Table 62. Global Paclitaxel for Injection Sales Market Share by Application (2019-2024)
Table 63. Global Paclitaxel for Injection Sales Market Share by Application (2025-2030)
Table 64. Global Paclitaxel for Injection Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Paclitaxel for Injection Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Paclitaxel for Injection Revenue Market Share by Application (2019-2024)
Table 67. Global Paclitaxel for Injection Revenue Market Share by Application (2025-2030)
Table 68. Global Paclitaxel for Injection Price (US$/Unit) by Application (2019-2024)
Table 69. Global Paclitaxel for Injection Price (US$/Unit) by Application (2025-2030)
Table 70. Getwell Pharmaceuticals Corporation Information
Table 71. Getwell Pharmaceuticals Description and Business Overview
Table 72. Getwell Pharmaceuticals Paclitaxel for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. Getwell Pharmaceuticals Paclitaxel for Injection Product
Table 74. Getwell Pharmaceuticals Recent Developments/Updates
Table 75. CSPC Pharmaceutical Group Limited Corporation Information
Table 76. CSPC Pharmaceutical Group Limited Description and Business Overview
Table 77. CSPC Pharmaceutical Group Limited Paclitaxel for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. CSPC Pharmaceutical Group Limited Paclitaxel for Injection Product
Table 79. CSPC Pharmaceutical Group Limited Recent Developments/Updates
Table 80. AdvaCare Pharma Corporation Information
Table 81. AdvaCare Pharma Description and Business Overview
Table 82. AdvaCare Pharma Paclitaxel for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. AdvaCare Pharma Paclitaxel for Injection Product
Table 84. AdvaCare Pharma Recent Developments/Updates
Table 85. Pfizer Corporation Information
Table 86. Pfizer Description and Business Overview
Table 87. Pfizer Paclitaxel for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. Pfizer Paclitaxel for Injection Product
Table 89. Pfizer Recent Developments/Updates
Table 90. Bristol-Myers Squibb Corporation Information
Table 91. Bristol-Myers Squibb Description and Business Overview
Table 92. Bristol-Myers Squibb Paclitaxel for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. Bristol-Myers Squibb Paclitaxel for Injection Product
Table 94. Bristol-Myers Squibb Recent Developments/Updates
Table 95. Celgene Corporation Corporation Information
Table 96. Celgene Corporation Description and Business Overview
Table 97. Celgene Corporation Paclitaxel for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. Celgene Corporation Paclitaxel for Injection Product
Table 99. Celgene Corporation Recent Developments/Updates
Table 100. Hospira Corporation Information
Table 101. Hospira Description and Business Overview
Table 102. Hospira Paclitaxel for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 103. Hospira Paclitaxel for Injection Product
Table 104. Hospira Recent Developments/Updates
Table 105. Biological E. Corporation Information
Table 106. Biological E. Description and Business Overview
Table 107. Biological E. Paclitaxel for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 108. Biological E. Paclitaxel for Injection Product
Table 109. Biological E. Recent Developments/Updates
Table 110. Taj Accura Corporation Information
Table 111. Taj Accura Description and Business Overview
Table 112. Taj Accura Paclitaxel for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 113. Taj Accura Paclitaxel for Injection Product
Table 114. Taj Accura Recent Developments/Updates
Table 115. Luye Pharma Corporation Information
Table 116. Luye Pharma Description and Business Overview
Table 117. Luye Pharma Paclitaxel for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 118. Luye Pharma Paclitaxel for Injection Product
Table 119. Luye Pharma Recent Developments/Updates
Table 120. Youcare Pharmaceutical Corporation Information
Table 121. Youcare Pharmaceutical Description and Business Overview
Table 122. Youcare Pharmaceutical Paclitaxel for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 123. Youcare Pharmaceutical Paclitaxel for Injection Product
Table 124. Youcare Pharmaceutical Recent Developments/Updates
Table 125. Hainan Chuntch Pharmaceutical Co Ltd Corporation Information
Table 126. Hainan Chuntch Pharmaceutical Co Ltd Description and Business Overview
Table 127. Hainan Chuntch Pharmaceutical Co Ltd Paclitaxel for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 128. Hainan Chuntch Pharmaceutical Co Ltd Paclitaxel for Injection Product
Table 129. Hainan Chuntch Pharmaceutical Co Ltd Recent Developments/Updates
Table 130. Healthiza Lifescience Private Limited Corporation Information
Table 131. Healthiza Lifescience Private Limited Description and Business Overview
Table 132. Healthiza Lifescience Private Limited Paclitaxel for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 133. Healthiza Lifescience Private Limited Paclitaxel for Injection Product
Table 134. Healthiza Lifescience Private Limited Recent Developments/Updates
Table 135. Beijing Union Pharmaceutical Factory Corporation Information
Table 136. Beijing Union Pharmaceutical Factory Description and Business Overview
Table 137. Beijing Union Pharmaceutical Factory Paclitaxel for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 138. Beijing Union Pharmaceutical Factory Paclitaxel for Injection Product
Table 139. Beijing Union Pharmaceutical Factory Recent Developments/Updates
Table 140. Hengrui Pharmaceuticals Corporation Information
Table 141. Hengrui Pharmaceuticals Description and Business Overview
Table 142. Hengrui Pharmaceuticals Paclitaxel for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 143. Hengrui Pharmaceuticals Paclitaxel for Injection Product
Table 144. Hengrui Pharmaceuticals Recent Developments/Updates
Table 145. Qilu Pharmaceutical Co., Ltd. Corporation Information
Table 146. Qilu Pharmaceutical Co., Ltd. Description and Business Overview
Table 147. Qilu Pharmaceutical Co., Ltd. Paclitaxel for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 148. Qilu Pharmaceutical Co., Ltd. Paclitaxel for Injection Product
Table 149. Qilu Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 150. Hainan Haiyao Corporation Information
Table 151. Hainan Haiyao Description and Business Overview
Table 152. Hainan Haiyao Paclitaxel for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 153. Hainan Haiyao Paclitaxel for Injection Product
Table 154. Hainan Haiyao Recent Developments/Updates
Table 155. Key Raw Materials Lists
Table 156. Raw Materials Key Suppliers Lists
Table 157. Paclitaxel for Injection Distributors List
Table 158. Paclitaxel for Injection Customers List
Table 159. Paclitaxel for Injection Market Trends
Table 160. Paclitaxel for Injection Market Drivers
Table 161. Paclitaxel for Injection Market Challenges
Table 162. Paclitaxel for Injection Market Restraints
Table 163. Research Programs/Design for This Report
Table 164. Key Data Information from Secondary Sources
Table 165. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Paclitaxel for Injection
Figure 2. Global Paclitaxel for Injection Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Paclitaxel for Injection Market Share by Type in 2023 & 2030
Figure 4. 5ml,30mg Product Picture
Figure 5. 10ml,60mg Product Picture
Figure 6. 16.7ml,100mg Product Picture
Figure 7. 25ml,150mg Product Picture
Figure 8. 50ml,300mg Product Picture
Figure 9. Global Paclitaxel for Injection Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 10. Global Paclitaxel for Injection Market Share by Application in 2023 & 2030
Figure 11. Ovarian Cancer
Figure 12. Breast Cancer
Figure 13. Cervical Cancer
Figure 14. Pancreatic Cancer
Figure 15. Others
Figure 16. Global Paclitaxel for Injection Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 17. Global Paclitaxel for Injection Market Size (2019-2030) & (US$ Million)
Figure 18. Global Paclitaxel for Injection Sales (2019-2030) & (K Units)
Figure 19. Global Paclitaxel for Injection Average Price (US$/Unit) & (2019-2030)
Figure 20. Paclitaxel for Injection Report Years Considered
Figure 21. Paclitaxel for Injection Sales Share by Manufacturers in 2023
Figure 22. Global Paclitaxel for Injection Revenue Share by Manufacturers in 2023
Figure 23. The Global 5 and 10 Largest Paclitaxel for Injection Players: Market Share by Revenue in 2023
Figure 24. Paclitaxel for Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 25. Global Paclitaxel for Injection Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 26. North America Paclitaxel for Injection Sales Market Share by Country (2019-2030)
Figure 27. North America Paclitaxel for Injection Revenue Market Share by Country (2019-2030)
Figure 28. United States Paclitaxel for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. Canada Paclitaxel for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Europe Paclitaxel for Injection Sales Market Share by Country (2019-2030)
Figure 31. Europe Paclitaxel for Injection Revenue Market Share by Country (2019-2030)
Figure 32. Germany Paclitaxel for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. France Paclitaxel for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. U.K. Paclitaxel for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Italy Paclitaxel for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. Russia Paclitaxel for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. Asia Pacific Paclitaxel for Injection Sales Market Share by Region (2019-2030)
Figure 38. Asia Pacific Paclitaxel for Injection Revenue Market Share by Region (2019-2030)
Figure 39. China Paclitaxel for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Japan Paclitaxel for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. South Korea Paclitaxel for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. India Paclitaxel for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Australia Paclitaxel for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. China Taiwan Paclitaxel for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Southeast Asia Paclitaxel for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Latin America Paclitaxel for Injection Sales Market Share by Country (2019-2030)
Figure 47. Latin America Paclitaxel for Injection Revenue Market Share by Country (2019-2030)
Figure 48. Mexico Paclitaxel for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Brazil Paclitaxel for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Argentina Paclitaxel for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. Middle East & Africa Paclitaxel for Injection Sales Market Share by Country (2019-2030)
Figure 52. Middle East & Africa Paclitaxel for Injection Revenue Market Share by Country (2019-2030)
Figure 53. Turkey Paclitaxel for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. Saudi Arabia Paclitaxel for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 55. UAE Paclitaxel for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 56. Global Sales Market Share of Paclitaxel for Injection by Type (2019-2030)
Figure 57. Global Revenue Market Share of Paclitaxel for Injection by Type (2019-2030)
Figure 58. Global Paclitaxel for Injection Price (US$/Unit) by Type (2019-2030)
Figure 59. Global Sales Market Share of Paclitaxel for Injection by Application (2019-2030)
Figure 60. Global Revenue Market Share of Paclitaxel for Injection by Application (2019-2030)
Figure 61. Global Paclitaxel for Injection Price (US$/Unit) by Application (2019-2030)
Figure 62. Paclitaxel for Injection Value Chain
Figure 63. Paclitaxel for Injection Production Process
Figure 64. Channels of Distribution (Direct Vs Distribution)
Figure 65. Distributors Profiles
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
